https://www.selleckchem.com/pr....oducts/Imatinib-Mesy
The third study uses conventional simultaneous brightness contrast displays, but an unusual group of participants Congenitally blind children whom we were able to treat surgically. The results demonstrate an immediate susceptibility to the simultaneous brightness illusion after sight onset. Together, these data strongly constrain the search for mechanisms underlying a fundamental brightness phenomenon.A novel series of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents were designed,